عاجل

Anthropic Fights Trump Administration Over AI Model Export Controls Trump and Iran Reach Initial Agreement to End War, Reopen Strait of Hormuz G7 Leaders Tackle Ukraine War, Middle East Crisis at Summit DC Voters Head to Polls for Mayor, Congressional Delegate Primaries Election Conspiracy Theorist Wins Nevada GOP Secretary of State Primary Isar Aerospace Faces New Delays in Spectrum Rocket Test Flights Former Louisville Officer Charged with Manslaughter in Fatal Shooting Google CEO Sundar Pichai Faces Student Protest at Stanford Commencement Former ICE Acting Director Todd Lyons Hired by Defense Contractor Georgia GOP Primary Runoff Exposes Party Divisions Anthropic Fights Trump Administration Over AI Model Export Controls Trump and Iran Reach Initial Agreement to End War, Reopen Strait of Hormuz G7 Leaders Tackle Ukraine War, Middle East Crisis at Summit DC Voters Head to Polls for Mayor, Congressional Delegate Primaries Election Conspiracy Theorist Wins Nevada GOP Secretary of State Primary Isar Aerospace Faces New Delays in Spectrum Rocket Test Flights Former Louisville Officer Charged with Manslaughter in Fatal Shooting Google CEO Sundar Pichai Faces Student Protest at Stanford Commencement Former ICE Acting Director Todd Lyons Hired by Defense Contractor Georgia GOP Primary Runoff Exposes Party Divisions

تسجيل الدخول

GLP-1 receptor agonist

مستقر2 خبر2 مصادرآخر تحديث: 4 g önce

وسوم ذات صلةWegovy semaglutide obesity weight loss MHRA Novo Nordisk BMI NHS

أحدث الأخبار

UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options

4 g önceملخص الذكاء الاصطناعي

UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options

The UK's MHRA has approved Wegovy, the first GLP-1 receptor agonist tablet for weight loss, making the UK the third country to authorize the pills. This expands treatment options for adults with obesity or overweight with related health conditions.

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

4 g önceملخص الذكاء الاصطناعي

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

The UK's MHRA has approved the first GLP-1 receptor agonist tablet, semaglutide (Wegovy), for weight loss and management. This daily pill offers a more convenient alternative to weekly injections for adults with obesity or those overweight with weight-related conditions.